glp-1 covered by cigna Health insurer will stop covering weight loss drugs in its employee health plan Cigna's Evernorth launches Wegovy, Zepbound

Long-term cardiovascular evidence for orforglipron is still accumulating

10.1016/S0140-6736(18)32261-X

Pharmacologic approaches to glycemic treatment: Standards of care in diabetes2023

In addition to weight management, GLP-1 medications may also help reduce the risk of related conditions such as heart disease, high blood pressure, and elevated cholesterol levels

GLP-1 agonists excel at weight reduction and cardiovascular protection, while SGLT2 inhibitors lead in renal preservation and heart failure management

The Cochrans Q test and the MR Egger intercept test showed no evidence of significant heterogeneity or pleiotropy, which aligned with the core assumptions of MR